Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase Ⅳ clinical trials.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2764, doi. 10.4268/cjcmm20112001
- By:
- Publication type:
- Article
Works matching IS 10015302 AND DT 2011 AND VI 36 AND IP 20
Results: 70
1
2
Study on method on post-marketing traditional Chinese medicine safety assessment.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2771, doi. 10.4268/cjcmm20112003
- By:
- Publication type:
- Article
3
Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2768, doi. 10.4268/cjcmm20112002
- By:
- Publication type:
- Article
4
Thought on several problems of post-marketing herbs clinical evaluation in special populations.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2776, doi. 10.4268/cjcmm20112004
- By:
- Publication type:
- Article
5
Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2779, doi. 10.4268/cjcmm20112005
- By:
- Publication type:
- Article
6
Study on 10409 cases of post-marketing safety Danhong injection centralized monitoring of hospital.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2783, doi. 10.4268/cjcmm20112006
- By:
- Publication type:
- Article
7
Comparative study on four kinds of assessment methods of post-marketing safety of Danhong injection.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2786, doi. 10.4268/cjcmm20112007
- By:
- Publication type:
- Article
8
Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2789, doi. 10.4268/cjcmm20112008
- By:
- Publication type:
- Article
9
Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2793, doi. 10.4268/cjcmm20112009
- By:
- Publication type:
- Article
10
Application of nested case-control study on safe evaluation of post-marketing traditional Chinese medicine injection.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2796, doi. 10.4268/cjcmm20112010
- By:
- Publication type:
- Article
11
Strategy of individualized screening of allergens in serum of patients allergic to Shuanghuanglian injection based on RBL-2H3 mast cell model.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2799, doi. 10.4268/cjcmm20112011
- By:
- Publication type:
- Article
12
Clinical re-evaluation of effects of different treatments to prevent from phlebitis induced by Chansu injection.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2803, doi. 10.4268/cjcmm20112012
- By:
- Publication type:
- Article
13
Evaluation point of rational drug use of traditional Chinese medicine in market.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2807, doi. 10.4268/cjcmm20112013
- By:
- Publication type:
- Article
14
Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2811, doi. 10.4268/cjcmm20112014
- By:
- Publication type:
- Article
15
Exploring real world: analysis about Shenmai injection data extracted from hospital information system database in clinical practice.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2813, doi. 10.4268/cjcmm20112015
- By:
- Publication type:
- Article
16
Case study of Chinese medicine after listing of pharmacovigilance.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2836, doi. 10.4268/cjcmm20112021
- By:
- Publication type:
- Article
17
Analysis of clinical use of Danhong injection based on hospital information system.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2817, doi. 10.4268/cjcmm20112016
- By:
- Publication type:
- Article
18
Guidance of FDA risk evaluation and mitigation strategy and enlightenment to drug risk management of post-marketing Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2825, doi. 10.4268/cjcmm20112018
- By:
- Publication type:
- Article
19
Study on building index system of risk assessment of post-marketing Chinese patent medicine based on AHP-fuzzy neural network.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2828, doi. 10.4268/cjcmm20112030
- By:
- Publication type:
- Article
20
Pharmacovigilance of major pharmaceutical innovation.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2831, doi. 10.4268/cjcmm20112020
- By:
- Publication type:
- Article
21
Analysis of using Danhong injection to treatment coronary heart disease patient’s medicines based on real world HIS database.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2821, doi. 10.4268/cjcmm20112017
- By:
- Publication type:
- Article
22
Interpretation of modified prescription for pharmacoeconomic analysis of New Zealand.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2840, doi. 10.4268/cjcmm20112022
- By:
- Publication type:
- Article
23
Application of Markov model in post-marketing pharmacoeconomic evaluation of traditional Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2844, doi. 10.4268/cjcmm20112023
- By:
- Publication type:
- Article
24
Process and key points of clinical literature evaluation of post-marketing traditional Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2848, doi. 10.4268/cjcmm20112024
- By:
- Publication type:
- Article
25
Literature review of post-marketing clinical evaluation of Xiaoke pill.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2851, doi. 10.4268/cjcmm20112025
- By:
- Publication type:
- Article
26
Study on clinical literature of Xiaoke pill's adverse reaction based on experts' evaluation.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2855, doi. 10.4268/cjcmm20112026
- By:
- Publication type:
- Article
27
Designs and thoughts of real world integrated data warehouse from HIS on re-evaluation of post-marketing traditional Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2880, doi. 10.4268/cjcmm20112033
- By:
- Publication type:
- Article
28
Survey on Xiaoke pill treating diabetes mellitus in small cities’ Chinese medicine hospital for post-marketing surveillance.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2859, doi. 10.4268/cjcmm20112027
- By:
- Publication type:
- Article
29
Study of population pharmacokinetic model and parameter analyses for multiple components in Chinese matria medica formula.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2866, doi. 10.4268/cjcmm20112029
- By:
- Publication type:
- Article
30
Key elements of design about PPK of Chinese medicine after marketing.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2871, doi. 10.4268/cjcmm20112030
- By:
- Publication type:
- Article
31
Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2874, doi. 10.4268/cjcmm20112031
- By:
- Publication type:
- Article
32
Skin test: guide of post-marketed re-evaluation of clinical safety in traditional Chinese medicine injection.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2877, doi. 10.4268/cjcmm20112032
- By:
- Publication type:
- Article
33
Study on adverse drug reaction in Yuixngcao injection literatures.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2862, doi. 10.4268/cjcmm20112028
- By:
- Publication type:
- Article
34
Construction and realization of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2883, doi. 10.4268/cjcmm20112034
- By:
- Publication type:
- Article
35
Application of regular expression in extracting key information from Chinese medicine literatures about re-evaluation of post-marketing surveillance.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2888, doi. 10.4268/cjcmm20112035
- By:
- Publication type:
- Article
36
Discussion on appraisal methods and key technologies of arbuscaular mycorrhizal fungi and medicinal plant symbosis system.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3051, doi. 10.4268/cjcmm20112130
- By:
- Publication type:
- Article
37
Clinical orientation and thought on several problems in post-marketed reassessment of traditional Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2893, doi. 10.4268/cjcmm20112036
- By:
- Publication type:
- Article
38
Ethical consideration in several commonly used study design.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2901, doi. 10.4268/cjcmm20112038
- By:
- Publication type:
- Article
39
Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2904, doi. 10.4268/cjcmm20112039
- By:
- Publication type:
- Article
40
Textual research on original plant and dietotherapy history of Prunella vulgaris.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3057, doi. 10.4268/cjcmm20112131
- By:
- Publication type:
- Article
41
Research about re-evaluation of screening of traditional Chinese medicine symptoms item of post-marketing medicine Xuezhikang.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 2898, doi. 10.4268/cjcmm20112037
- By:
- Publication type:
- Article
42
Safety research in Chinese medicines based on application of data mining.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3047, doi. 10.4268/cjcmm20112129
- By:
- Publication type:
- Article
43
Research on therapeutic effect and hemorrheology change of berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3032, doi. 10.4268/cjcmm20112127
- By:
- Publication type:
- Article
44
Research progress of antitumor components from original animals of traditional Chinese medicine powder of Notarchus.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3038, doi. 10.4268/cjcmm20112128
- By:
- Publication type:
- Article
45
Explaining syndromes of decoction for removing blood stasis in chest.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3026, doi. 10.4268/cjcmm20112126
- By:
- Publication type:
- Article
46
Effect and mechanisms of Shenmai injection on contractions of porcine coronary artery.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3023, doi. 10.4268/cjcmm20112125
- By:
- Publication type:
- Article
47
Research on relationship between tissue quantitative distribution of ³H-achyranthes bidentata ecdysterone and channel-tropism of herbal drugs in mice.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3018, doi. 10.4268/cjcmm20112124
- By:
- Publication type:
- Article
48
Effect and mechanism of Andrographitis Herba on human CD4<sup>+</sup>T cell Promoters CXCR4 and CCR5.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3012, doi. 10.4268/cjcmm20112123
- By:
- Publication type:
- Article
49
Molecular mechanism of tetramethylpyrazine to induce human promyelocytic HL-60 leukemia cells differentiation.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3007, doi. 10.4268/cjcmm20112122
- By:
- Publication type:
- Article
50
Research of therapeutical effect and immunologic mechanism of Jiawei Foshou San on model rats of endometriosis.
- Published in:
- China Journal of Chinese Materia Medica, 2011, v. 36, n. 20, p. 3001, doi. 10.4268/cjcmm20112121
- By:
- Publication type:
- Article